Lorraine Kalia, MD, PhD - University of Toronto, Toronto, Canada
Sheng-Han Kuo, MD - Columbia University, New York, United States
Helen M. Bronte-Stewart, MD, MSE - Stanford University, Stanford, CA, USA
Michael Schlossmacher, MD - The Ottawa Hospital, Ottawa, ON, Canada
Peter K. Todd, MD, PhD - University of Michigan, Ann Arbor, MI, USA
The primary purpose of this course is aimed at addressing the significance of translational research in movement disorders. The primary objectives are to inspire basic scientists to undertake research with direct clinical relevance, and to equip clinicians with the foundational knowledge required to utilize upcoming diagnostic tests and therapies effectively.
The program facilitates collaborative learning between basic scientists and clinicians, encouraging future partnerships in the field of movement disorders. By addressing current hot topics that bridge the gap between the lab and the clinic, this series seeks to foster a collaborative environment that will yield valuable insights and advancements in translational research.